| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Doklady Biochemistry and Biophysics | ||
| Dergi ISSN | 1607-6729 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 04-2025 |
| Cilt / Sayı / Sayfa | 521 / 1 / 221–231 | DOI | 10.1134/S1607672924601276 |
| Makale Linki | https://doi.org/10.1134/s1607672924601276 | ||
| Özet |
| Cisplatin (CIS) is widely used in the treatment of laryngeal cancer, one of the most common and lethal cancers. However, it is not a satisfactory chemotherapeutic agent. Therefore, there is a need to identify new agents, such as gallic acid (GAL), that can exert a synergistic effect to elucidate the pathophysiological mechanisms of the chemotherapeutic effects of CIS and to increase the effectiveness of treatment by preventing drug resistance. For this purpose, we investigated the stimulatory role of GAL on CIS-induced human laryngeal cancer (Hep-2) cell death via TRPM2 channel activation. For the study, four groups were formed from human laryngeal cancer (Hep-2) cells as Control, GAL (1OO μM), CIS (25 μM), and GAL + CIS. In the analyses made, cell viability, glutathione (GSH) and glutathione peroxidase (GSH-Px) enzyme activity, lipid peroxidation (LPx) levels, inflammation markers I-1β, IL-6, and TNF-α, Total … |
| Anahtar Kelimeler |
| cisplatin | gallic acid | HEp-2 cell | oxidative stress | PARP-1 | TRPM2 |
| Atıf Sayıları | |
| Web of Science | 2 |
| Scopus | 3 |
| Google Scholar | 3 |
| Dergi Adı | Doklady Biochemistry and Biophysics |
| Yayıncı | Pleiades Publishing |
| Açık Erişim | Hayır |
| ISSN | 1607-6729 |
| E-ISSN | 1608-3091 |
| CiteScore | 1,5 |
| SJR | 0,223 |
| SNIP | 0,310 |